Indeed, we and others have demonstrated that pharmacologic intervention against mediators of pro-inflammatory signaling, including c-Jun N-terminal kinase (Jnk) [5] and nuclear factor kappa B (NFκB) [6] are effective in suppressing tissue destruction in a mouse model of AAA. The gene discussed is MAPK8; the disease is triple-A syndrome.